Dade Behring
This article was originally published in The Gray Sheet
Executive Summary
Equity stake in the clinical diagnostics firm by diversified drug maker Hoechst AG will increase to approximately 50% following the completion of a $400 mil. share repurchase program by Dade Behring. However, non-Hoechst AG shareholders, including Bain Capital, Goldman Sachs and company management, will continue to hold voting control. Hoechst AG currently holds a 32.5% share of Dade Behring
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.